Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.
DALYs
deaths
digestive diseases
global burden of disease
incidence
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
04
2023
accepted:
08
08
2023
medline:
12
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
The global burden of digestive diseases has been rising in the last 30 years. The rates and trends of incidence, deaths, and disability-adjusted life-years (DALYs) for digestive diseases need to be investigated. We extracted the data on overall digestive diseases and by cause between 1990-2019 from the Global Burden of Diseases 2019 website, including the absolute number and the corresponding age-standardized rates of incidence (ASIR), deaths (ASDR), and DALYs (ASDALYs). Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. The sociodemographic index (SDI) of overall digestive diseases showed a slight increase in ASIR from low to middle-low regions. The downtrend in ASDR and ASDALYs was found in all SDI regions. The burden of incidence was higher in females, while the burden of deaths and DALYs was higher in males for the overall digestive diseases and most causes. The estimated annual percentage changes were significantly associated with the baseline ASIR, ASDR, and ASDALYs for the overall digestive diseases, and the negative correlations between ASDR, ASDALYs, and human development index both in 1990 ( The findings indicate that digestive diseases remain a significant public health burden, with substantial variation across countries, sexes, and age groups. Therefore, implementing age, gender, and country-specific policies for early screening and targeted interventions could significantly reduce the global burden of digestive diseases.
Sections du résumé
Background
The global burden of digestive diseases has been rising in the last 30 years. The rates and trends of incidence, deaths, and disability-adjusted life-years (DALYs) for digestive diseases need to be investigated.
Methods
We extracted the data on overall digestive diseases and by cause between 1990-2019 from the Global Burden of Diseases 2019 website, including the absolute number and the corresponding age-standardized rates of incidence (ASIR), deaths (ASDR), and DALYs (ASDALYs).
Results
Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. The sociodemographic index (SDI) of overall digestive diseases showed a slight increase in ASIR from low to middle-low regions. The downtrend in ASDR and ASDALYs was found in all SDI regions. The burden of incidence was higher in females, while the burden of deaths and DALYs was higher in males for the overall digestive diseases and most causes. The estimated annual percentage changes were significantly associated with the baseline ASIR, ASDR, and ASDALYs for the overall digestive diseases, and the negative correlations between ASDR, ASDALYs, and human development index both in 1990 (
Conclusion
The findings indicate that digestive diseases remain a significant public health burden, with substantial variation across countries, sexes, and age groups. Therefore, implementing age, gender, and country-specific policies for early screening and targeted interventions could significantly reduce the global burden of digestive diseases.
Identifiants
pubmed: 37693711
doi: 10.3389/fpubh.2023.1202980
pmc: PMC10483149
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1202980Informations de copyright
Copyright © 2023 Wang, Hu, Sun, Yan, Wang, Wang, Zhang, Meng, Zhai, Zong, Hu, Yu and Zou.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pancreatology. 2014 Nov-Dec;14(6):490-6
pubmed: 25224249
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Prz Gastroenterol. 2022;17(1):47-51
pubmed: 35371356
Nat Rev Dis Primers. 2017 Sep 07;3:17060
pubmed: 28880010
Gastroenterology. 2013 Jun;144(6):1252-61
pubmed: 23622135
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266
pubmed: 31981519
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Nutr Clin Pract. 2017 Jun;32(3):296-308
pubmed: 28537517
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Lancet Neurol. 2021 Oct;20(10):795-820
pubmed: 34487721
Surg Clin North Am. 2015 Dec;95(6):1105-22, v
pubmed: 26596917
Rheumatology (Oxford). 2017 Aug 1;56(8):1254-1263
pubmed: 27686101
Gastroenterology. 2019 Jan;156(1):254-272.e11
pubmed: 30315778
Am J Gastroenterol. 2001 Jul;96(7):2117-25
pubmed: 11467642
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7
pubmed: 26323879
Ann Rheum Dis. 2020 Aug;79(8):1014-1022
pubmed: 32414807
Lancet. 2016 Nov 12;388(10058):2386-2402
pubmed: 27720260
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947
pubmed: 31648972
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30
pubmed: 31648971